STAT3 and neoplasm: By studying the induction of apoptosis in NSCLC and A549 cells, Qian et al. [49] demonstrated that ATL I has significant anti-tumor activity, not only activating ERK1/2 to inhibit SP1 protein levels, but also decreasing Stat3 protein levels, thereby inhibiting PDK1 expression.